|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Operating costs and expenses: | ||
| Research and development, net (Note 9) | $ 4,772 | $ 2,917 |
| General and administrative | 2,649 | 2,126 |
| Total operating costs and expenses | 7,421 | 5,043 |
| Financial expenses (income), net | 1,825 | (144) |
| Operating loss | 9,246 | 4,899 |
| Taxes on income (Note 10) | 0 | 0 |
| Net loss | $ 9,246 | $ 4,899 |
| Basic and diluted net loss per share from continuing operations (in dollars per share) | $ 0.68 | $ 0.46 |
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) | 13,662,758 | 10,738,131 |